Safety and Activity of HF50 in Patients With Advanced Solid Tumors
Clinical trial NCT07601334 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07601334
- Sponsor
- HighField Biopharmaceuticals Corporation
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2028-06-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.